Stay updated on INTEGA: Ipilimumab & FOLFOX + Nivolumab & Trastuzumab Clinical Trial

Sign up to get notified when there's something new on the INTEGA: Ipilimumab & FOLFOX + Nivolumab & Trastuzumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the INTEGA: Ipilimumab & FOLFOX + Nivolumab & Trastuzumab Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page now displays the INTEGA phase 2 study record, including its treatment strategies, eligibility criteria, outcome measures, study locations, and publications, instead of a 403 error.
    Difference
    66%
    Check dated 2026-11-11T00:59:17.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0; the page continues to display a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-03T23:21:25.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    A banner announces an NIH-wide transition from the term “Artificial Intelligence” to “Super Intelligence.” The site revision label changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T22:53:28.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1; the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-06T22:56:21.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the expected study details and indicating restricted access to the record.
    Difference
    18%
    Check dated 2026-09-22T23:11:25.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The revision label on the page updated from v3.6.6 to v3.7.0, indicating a newer page revision. This typically reflects maintenance or minor improvements rather than changes to study data or content.
    Difference
    0.0%
    Check dated 2026-09-15T21:46:12.000Z thumbnail image

Stay in the know with updates to INTEGA: Ipilimumab & FOLFOX + Nivolumab & Trastuzumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the INTEGA: Ipilimumab & FOLFOX + Nivolumab & Trastuzumab Clinical Trial page.